Revvity, Inc. (NYSE:RVTY - Free Report) - Analysts at Zacks Research raised their Q1 2026 earnings estimates for Revvity in a research note issued to investors on Monday, May 19th. Zacks Research analyst R. Department now forecasts that the company will earn $1.11 per share for the quarter, up from their previous estimate of $1.10. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Zacks Research also issued estimates for Revvity's Q4 2026 earnings at $1.58 EPS.
Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, April 28th. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.96 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The business had revenue of $664.76 million for the quarter, compared to the consensus estimate of $662.30 million. During the same quarter last year, the business posted $0.98 EPS. The firm's revenue was up 2.3% compared to the same quarter last year.
RVTY has been the topic of several other reports. Robert W. Baird dropped their target price on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. JPMorgan Chase & Co. dropped their price objective on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a report on Tuesday, April 29th. The Goldman Sachs Group reduced their target price on shares of Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. KeyCorp increased their target price on Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Finally, Raymond James restated an "outperform" rating and issued a $120.00 price target (down from $145.00) on shares of Revvity in a report on Tuesday, April 29th. Four equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Revvity currently has an average rating of "Moderate Buy" and a consensus target price of $125.64.
Check Out Our Latest Research Report on Revvity
Revvity Trading Down 4.0%
NYSE RVTY opened at $89.86 on Thursday. Revvity has a one year low of $88.53 and a one year high of $129.50. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The firm has a market cap of $10.59 billion, a P/E ratio of 40.66, a P/E/G ratio of 3.82 and a beta of 1.02. The stock's 50-day moving average is $97.62 and its 200-day moving average is $109.81.
Hedge Funds Weigh In On Revvity
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in RVTY. Nissay Asset Management Corp Japan ADV raised its position in shares of Revvity by 0.6% in the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 15,023 shares of the company's stock valued at $1,682,000 after purchasing an additional 91 shares during the period. Quarry LP lifted its position in Revvity by 45.7% during the fourth quarter. Quarry LP now owns 303 shares of the company's stock worth $34,000 after acquiring an additional 95 shares during the last quarter. HB Wealth Management LLC boosted its holdings in shares of Revvity by 4.6% during the fourth quarter. HB Wealth Management LLC now owns 2,380 shares of the company's stock worth $266,000 after acquiring an additional 104 shares during the period. Signaturefd LLC boosted its stake in Revvity by 6.8% in the 4th quarter. Signaturefd LLC now owns 1,668 shares of the company's stock valued at $186,000 after purchasing an additional 106 shares during the period. Finally, Westside Investment Management Inc. grew its holdings in Revvity by 0.8% in the 4th quarter. Westside Investment Management Inc. now owns 14,363 shares of the company's stock valued at $1,603,000 after buying an additional 108 shares in the last quarter. 86.65% of the stock is owned by institutional investors.
Revvity Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Shareholders of record on Friday, July 18th will be paid a $0.07 dividend. The ex-dividend date is Friday, July 18th. This represents a $0.28 annualized dividend and a yield of 0.31%. Revvity's dividend payout ratio is 11.91%.
Revvity Company Profile
(
Get Free Report)
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.